Does creatine help muscle after 50? What the meta-analyses actually found

Five systematic reviews pooled randomized trials in older adults that compared creatine with a placebo or with no supplement. In four of them, every trial gave both groups the same resistance training program, which isolates what creatine adds on top of training, the question that matters. The fifth, in postmenopausal women, also pooled trials without training. Every one found a benefit on at least one strength measure. They disagree about how large it is and about whether muscle mass itself changes.

A standardized effect size expresses a difference in units of how much people vary, which lets a review pool trials that tested strength on different machines. The Yao review, the newest and the only one restricted to people 60 and over, describes its 0.31 as small, and rated the certainty of that strength finding moderate. Its muscle-mass and physical-function estimates had confidence intervals that crossed zero.

Three things keep the table from being a simple yes.

Early lean mass gains can be water. Creatine can draw water into muscle in the first days of taking it. A 2021 review by creatine researchers says lean mass increases occasionally attributed to creatine in short-term studies, of about a week, are likely explained by increased body water, while other studies suggest creatine does not change body water relative to muscle mass over longer periods. The trials in these reviews ran for weeks to two years, not days. Strength does not depend on how a scan reads body composition, and the pooled strength effects are small.

Function is the least certain outcome. Devries and Phillips found a better 30-second chair stand result with creatine (P = 0.03). The 2026 Yao review found no significant effect on physical function, with very low certainty. A 2024 review of 33 trials in older adults and people with chronic disease found a sit-to-stand benefit in the six trials that measured it (SMD 0.51) but rated all its evidence low or very low quality because of high risk of bias.

Much of the field is industry-connected. The 2021 dosing review, the 2021 review in older women, the 2021 questions-and-misconceptions paper and the 2026 postmenopausal review each declare authors who advise or have advised creatine manufacturers or sellers, including Alzchem. The reviews that declare no competing interests (Chilibeck 2017, Liu 2025, Yao 2026) find the same direction. The most recent and most restrictive of them puts the strength effect at small and could not confirm a muscle-mass effect.

Every positive estimate above comes from trials where people were lifting. The 2021 questions-and-misconceptions review, written by researchers broadly in favor of creatine, states that creatine alone, without a resistance training program, is unlikely to produce substantial gains in muscle strength and functional performance. Its authors had tested it directly: postmenopausal women taking 3 g a day for two years did not gain lean mass.

The 2026 postmenopausal review drew the same line in its own data. Benefits appeared when 5 g a day or more was combined with resistance training, and trials using 3 g a day or less without training showed no measurable effect.

This is the same pattern our guide to protein after 40 found: the supplement is conditional on the training. If you are not doing resistance exercise, start there. Our guide to muscle after 40 and strength training sets out the evidence and the floor.

For older women the evidence is thinner than for older adults overall. A 2021 review of 10 trials and 211 older women found creatine increased upper-body strength overall (p = 0.04) with no effect on lower-body strength or muscle mass. In trials lasting 24 weeks or more, both upper-body (p = 0.05) and lower-body strength (p = 0.03) improved.

The 2026 postmenopausal review pooled 7 trials and 608 women, with and without resistance training: 0.37 kg more lean mass, from five trials and 338 women, and 7.5 kg more on the leg press, from three trials and 111 women.

Bone is where the claims run furthest ahead of the data. A 2018 meta-analysis of five trials and 193 adults over 50 or postmenopausal found no greater effect of creatine plus training than training alone on whole-body, hip, femoral neck or lumbar spine bone density. The 2026 review found bone density unchanged overall. For bone, the evidence-backed intervention is the loading exercise itself, which we cover in the best exercise to prevent osteoporosis.

In the 22 trials Chilibeck pooled, eight began with a loading phase of 20 g a day for 5 to 7 days. The review gives dosing after that, and in the other trials, as 3 to 5 g a day, although its own trial table also lists trials dosed by body weight, at 0.1 g per kilogram a day. In the Liu review, six of eight trials dosed by body weight at 0.1 g per kilogram a day, which is 7 g for a 70 kg (154 lb) person by our arithmetic.

Loading is optional. The 2021 review states that about 3 to 5 g a day for a minimum of four weeks reaches similar muscle saturation. The evidence on whether loading changes the result is split: a 2021 dosing meta-analysis found that once loading-phase studies were excluded, creatine no longer showed a greater effect on chest or leg press, while the 2026 Yao review found neither dose nor loading was a stable source of variation in effect. The 2021 review concluded that other forms of creatine are not superior to creatine monohydrate.

The trials in older adults report few problems. Chilibeck found gastrointestinal adverse events in four studies and muscle cramping in two; none caused participants to withdraw, and five studies that checked liver or kidney function by blood or urine testing found no adverse effects. The Liu review recorded transient gastrointestinal discomfort and mild cramping, with no serious adverse events. In the postmenopausal trials, adverse events were mild and similar to placebo and kidney measures were unchanged.

Expect some early weight gain. Water retention in the first several days is the most common effect the 2021 review identifies. The hair-loss worry traces to a single 2009 study in young rugby players that found a rise in dihydrotestosterone; it has not been replicated.

The effect that matters most after 50 is on your blood work. Creatine breaks down into creatinine, and a 2025 meta-analysis found creatine supplementation produces a small but statistically significant rise in serum creatinine with no significant change in GFR. Because eGFR is calculated from creatinine, a higher creatinine pulls the estimate down. Our guide to high creatinine without kidney damage walks through that review and its limits, including that none of its trials enrolled people with chronic kidney disease. If you have reduced kidney function, the safety data do not cover you.

If you take creatine, tell whoever orders or reads your kidney tests, so a creatinine rise is read in context. Our eGFR reference page carries the ranges with their source and date, and the lab result lookup will place a specific value against them. If you have not started resistance training, our guide to strength training after 40 is the place to begin, because that is the part of this the evidence says does most of the work.

Before starting creatine if you have chronic kidney disease or a reduced eGFR, because the trials that measured kidney safety did not include people with kidney disease. Before starting a new resistance program if you have a heart condition or a recent injury. And if you are losing strength or muscle noticeably without a clear reason, that deserves an assessment, not a supplement.